Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › zoledronate

zoledronate

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of zoledronate

2 trials tracked of zoledronate.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 Zoledronate With Atorvastatin in Renal Cell Carcinoma Completed
  2. Phase 2 Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Antiresorptive and Anabolic Agents Improve Bone Microarchitecture in Postmenopausal Women With Type 2 Diabetes: Pilot RCT
Diabetes & Endocrinology RCT
Antiresorptive and Anabolic Agents Improve Bone Microarchitecture in Postmenopausal Women With Type 2 Diabetes: Pilot RCT Diabetes Weakens Bones: One Drug Builds Them Back
This pilot randomized controlled trial evaluated antiresorptive and anabolic agents in 129 postmenopausal women with Type 2 Diabetes.
Building new bone tissue with a specific daily shot works better than just protecting existing bone for women with diabetes.
Apr 22, 2026
Bisphosphonates reduce vertebral fracture risk in multiple myeloma, spinal cord compression effect unclear
Orthopedics & Sports Medicine Meta-analysis
Bisphosphonates reduce vertebral fracture risk in multiple myeloma, spinal cord compression effect unclear Can bone drugs protect the spine in multiple myeloma? A new review weighs in
A meta-analysis of 11 randomized trials in adults with multiple myeloma found bisphosphonates reduced vertebral fracture risk compared to no…
Bone drugs called bisphosphonates lower the risk of spine fractures in multiple myeloma patients, though evidence on preventing spinal cord …
Apr 2, 2026